Austria Enhances Support for Rare Disease Patients with Fresh Centers and Leadership

For individuals facing the challenges of a rare disease, a timely and accurate diagnosis can be a long and arduous journey. In Austria, approximately 450,000 people live with a rare disease, often navigating years of uncertainty before receiving a diagnosis.¹ However, recent developments in specialized care centers and organizational leadership are offering renewed hope and improved support for these patients.

The Diagnostic Odyssey and the Need for Specialized Care

A disease is defined as rare in the European Union when it affects no more than one in 2,000 people.¹ Despite this relatively low incidence for any single disease, rare diseases collectively affect around 5% of the population.¹ Worldwide, between 6,000 and 8,000 different rare diseases have been identified, with approximately 72% having a genetic basis and 70% manifesting in childhood.¹

The path to diagnosis is often lengthy, averaging around five years in Austria.¹ This “diagnostic odyssey” can be both medically and psychologically taxing, as patients frequently consult multiple doctors, receive conflicting information, or are given only preliminary diagnoses. Women, in particular, have reported that their concerns are often dismissed or not taken seriously.¹

Expanding Network of Expert Centers

To address these challenges, Austria has been expanding its network of specialized care centers. Currently, there are over 50 Type B centers of expertise located at university hospitals in Vienna, Innsbruck, Linz, Graz, and Salzburg.¹ These centers serve as hubs, bringing together specialists to facilitate accurate diagnoses, develop tailored treatment plans, assist with medication access, and provide support for daily living. They aim to be accessible points of contact for both patients and general practitioners.

These centers are now being integrated into Austria’s structural plan for healthcare, signaling a commitment to further expanding care options for individuals with rare diseases.¹

New Leadership at Pro Rare Austria

Pro Rare Austria, the alliance for rare diseases, has recently appointed Mag. Manuela Rosenberger as its new managing director, effective February 2026.¹, 3 Rosenberger brings extensive experience in networking, strategic planning, and leadership from previous roles in social organizations, including Volkshilfe Wien, the Federal Agency for Care and Support Services, and most recently, as managing director of “Rettet das Kind – Kärnten.”¹, 3

She succeeds Mag. Elisabeth Weigand, MBA, who led Pro Rare Austria from 2020 and will now focus on financial and fundraising responsibilities.¹, 3

Ongoing Challenges and Future Directions

Despite advancements in diagnosis and care, significant challenges remain. Currently, approved therapies are available for only around 6% of rare diseases.¹ Many treatments are costly, some require case-by-case approval, and access to rehabilitation services and specialized therapies can be limited.

The annual Rare Disease Day, observed on February 28th, serves as a global platform to raise awareness, advocate for equal opportunities, and improve access to diagnoses and treatments for those affected by rare diseases.¹